Glenmark Pharmaceuticals
GLENMARK.NS
$12.95
Share price
-0.09%
Change (1 day)
104.58%
Change (1 year)
Categories
Earnings for Glenmark Pharmaceuticals (GLENMARK.NS)
Earnings in 2023 (TTM): -$39.05 M
According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$39.05 M. In 2022 the company made an earning of $0.20 B a decrease over its 2021 earnings that were of $0.24 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Glenmark Pharmaceuticals from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$39.05 M | -118.64% |
| 2022 | $0.20 B | -13.93% |
| 2021 | $0.24 B | 4.71% |
| 2020 | $0.23 B | 18.75% |
| 2019 | $0.19 B | -15.94% |
| 2018 | $0.23 B | 36.53% |
| 2017 | $0.17 B | -31.83% |
| 2016 | $0.25 B | 66.83% |
| 2015 | $0.14 B | 8.58% |
| 2014 | $0.13 B | -18.39% |
| 2013 | $0.16 B | 3.67% |
| 2012 | $0.16 B |